Rachel Tetelbaum

Rachel Teitelbaum, PhD is the founder of Hervana Ltd. and acting chief executive officer of the company. Rachel earned her Ph.D. in microbiology and immunology at the Sue Golding Graduate Division of the Albert Einstein College of Medicine. Her academic research career spans more than 15 years and focused on research in infectious diseases, the development of animal models of infection and the development of vaccines for mucosal immunity. Rachel is also a registered patent agent in several jurisdictions and also serves as the Intellectual Property Advisor to Hervana.

Comments are closed.